News

Accelerated Protocol Identifies Lowest-Risk Cardio Admissions


 

FROM THE LANCET

Dr. Body disclosed having received past donations of research supplies from diagnostics firms owned by Roche, Siemens, and Alere, along with travel reimbursements from Roche and Randox.

The study was funded by Alere Medical, a maker of diagnostic tests and equipment, which provided grants and other direct funding to seven investigators and travel funding to eight others. Investigators in some countries received country-specific funding from other companies including Indonesian medical equipment maker, Medquest Jaya Global, and manufacturers Science International of Hong Kong, Bio Laboratories of Singapore and Progressive Group of Taiwan.

The sponsors had no role in the study or the report, the authors declared.

Pages

Recommended Reading

AHA Issues First Scientific Statement on Bariatric Surgery
MDedge Family Medicine
Continuing Warfarin During EVLT May Be Safe
MDedge Family Medicine
Generalized Anxiety Disorder Linked to Cardiovascular Mortality
MDedge Family Medicine
Clopidogrel Dosing Based on Platelet Reactivity Shows No Benefit in PCI Patients
MDedge Family Medicine
Study Questions Using Biomarker Targets to Improve CKD Outcomes
MDedge Family Medicine
Angina Less Frequent After CABG Than After PCI
MDedge Family Medicine
Medical Treatment, Surgery Relieve Venous Disease Symptoms
MDedge Family Medicine
Cardiac Risk Higher With Rosiglitazone Than Pioglitazone
MDedge Family Medicine
Dalteparin No Better Than Unfractionated Heparin for Preventing DVT
MDedge Family Medicine
Critical Care Phase in HLHS Extends Through Transfer From ICU to Floor
MDedge Family Medicine